Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $162.2 million.

  • Oncology Institute's Total Non-Current Liabilities fell 58.34% to $162.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year decrease of 58.34%. This contributed to the annual value of $168.7 million for FY2024, which is 1314.93% up from last year.
  • Oncology Institute's Total Non-Current Liabilities amounted to $162.2 million in Q3 2025, which was down 58.34% from $161.1 million recorded in Q2 2025.
  • Oncology Institute's 5-year Total Non-Current Liabilities high stood at $168.7 million for Q4 2024, and its period low was $11.6 million during Q1 2021.
  • Its 5-year average for Total Non-Current Liabilities is $116.7 million, with a median of $144.6 million in 2023.
  • As far as peak fluctuations go, Oncology Institute's Total Non-Current Liabilities soared by 79821.03% in 2022, and later tumbled by 306.89% in 2025.
  • Over the past 5 years, Oncology Institute's Total Non-Current Liabilities (Quarter) stood at $92.4 million in 2021, then surged by 45.63% to $134.5 million in 2022, then grew by 10.85% to $149.1 million in 2023, then increased by 13.15% to $168.7 million in 2024, then fell by 3.86% to $162.2 million in 2025.
  • Its Total Non-Current Liabilities stands at $162.2 million for Q3 2025, versus $161.1 million for Q2 2025 and $155.2 million for Q1 2025.